A 38-year-old woman from Delhi undergoes routine cervical cancer screening with liquid-based cytology as part of a health camp. Her Pap smear shows CIN-2 (cervical intraepithelial neoplasia grade 2). HPV testing is positive for HPV-31 (high-risk type). She has no prior abnormal smears and denies smoking. Colposcopy is planned. Which of the following best explains why this patient's lesion has a higher risk of progression to invasive cancer compared to an HPV-negative CIN-2?

Explanation

## HPV-Positive vs. HPV-Negative CIN: Molecular Basis of Progression Risk ### The Critical Difference: Persistent Viral Oncogene Expression **Key Point:** HPV-positive CIN-2 carries a much higher risk of progression to invasive cancer because the *persistent* presence of HPV E6 and E7 oncoproteins continuously suppresses p53 and Rb function, allowing accumulation of additional mutations without triggering apoptosis. ### Comparison: HPV+ CIN vs. HPV− CIN | Feature | HPV+ CIN-2 | HPV− CIN-2 | |---|---|---| | **E6/E7 expression** | Continuous (viral genome present) | Absent | | **p53 function** | Inactivated by E6 | Intact | | **Rb function** | Inactivated by E7 | Intact | | **Apoptosis in response to DNA damage** | Blocked (E6 degrades p53) | Normal (p53-mediated) | | **Genomic instability tolerance** | High (mutations accumulate) | Low (cells die or arrest) | | **Progression to invasive cancer (5-year risk)** | 30–40% | <5% | **High-Yield:** The presence of persistent HPV (especially high-risk types like HPV-31) is the single strongest predictor of CIN progression. HPV-negative CIN-2 often regresses spontaneously because the cell's normal p53/Rb checkpoints remain intact. ### Why Persistent Infection Drives Progression 1. **Continuous E6/E7 expression** → p53 and Rb remain inactivated 2. **Genomic damage accumulates** → mutations in PTEN, PIK3CA, TP53 (second hit), etc. 3. **p53-mediated apoptosis is blocked** → damaged cells survive instead of dying 4. **Cell cycle checkpoints are bypassed** → cells with DNA damage continue dividing 5. **Additional oncogenic hits accumulate** → transition from CIN-2 → CIN-3 → invasive carcinoma **Clinical Pearl:** In HPV-negative CIN-2, if the patient's immune system clears any causative agent (or if the lesion is caused by non-viral factors like smoking-induced damage), the normal p53/Rb checkpoints can restore order and the lesion may regress. This is why HPV-negative CIN-2 has a much better prognosis. ### Natural History of HPV+ CIN-2 ```mermaid flowchart TD A[HPV-31 infection]:::outcome --> B[Acute infection: episomal viral DNA]:::outcome B --> C{Immune clearance?}:::decision C -->|Yes<br/>40-50%| D[Regression]:::action C -->|No<br/>50-60%| E[Persistent infection]:::urgent E --> F[Continuous E6/E7 expression]:::outcome F --> G[p53 and Rb inactivated]:::outcome G --> H[Genomic instability + mutation accumulation]:::outcome H --> I[CIN-2]:::outcome I --> J{Additional hits?}:::decision J -->|Yes| K[CIN-3]:::outcome J -->|No| L[Stable CIN-2]:::outcome K --> M[Invasive cervical cancer]:::urgent L --> N[May persist or regress slowly]:::action ``` **Mnemonic:** **PERsistent = PERfect storm** for cancer. Persistent HPV = Persistent E6/E7 = Persistent p53/Rb inactivation = Permissive environment for mutation accumulation.